Newsletter Subscription

Enter Name and Email

14 June 2011 - Adrian to present at 24th ECNP Congress in Paris

Adrian Newman-Tancredi Ph.D. will be co-leading a Brainstorming Session at the 24th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Paris from 3rd to 7th September 2011. The session will examine perspectives for the management of schizophrenia in a context where several major antipsychotics are nearing the end of their patent lives. What are the implications for drug discovery and clinical practice?
Adrian has extensive experience of antipsychotics pharmacology and drug discovery and has presented to a wide variety of audiences. If you are attending the conference, Adrian would be happy to meet and discuss with you: Contact.


Brainstorming Session Title:
Antipsychotics in the post-patent cliff era: challenges for clinical and drug discovery research.

Session BS.7, Tuesday, September 06, 2011 from 07.45 - 08.45 hours.

Chair:    Dieter Naber, Germany
Expert:  Adrian Newman-Tancredi, France
Expert:  Erik Wong, USA


For full details of the ECNP Congress click here.